-
Je něco špatně v tomto záznamu ?
MicroRNAs in the key events of systemic lupus erythematosus pathogenesis
M. Husakova
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, přehledy
Grantová podpora
NT13707
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
Free Medical Journals od 1998
Medline Complete (EBSCOhost) od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources od 2001
Odkazy
PubMed
27003314
DOI
10.5507/bp.2016.004
Knihovny.cz E-zdroje
- MeSH
- adaptivní imunita fyziologie MeSH
- B-lymfocyty imunologie MeSH
- estrogeny fyziologie MeSH
- genetická predispozice k nemoci MeSH
- jednonukleotidový polymorfismus genetika MeSH
- lidé MeSH
- mikro RNA genetika fyziologie MeSH
- modely nemocí na zvířatech MeSH
- myši MeSH
- přirozená imunita fyziologie MeSH
- systémový lupus erythematodes etiologie genetika imunologie MeSH
- T-lymfocyty imunologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
BACKGROUND: Small non-coding RNA molecules (miRs) are involved in immune cell maturation and function and might influence immunopathological processes of systemic lupus erythematosus (SLE) pathogenesis. METHODS AND RESULTS: This paper presents the results of a literature search for publications dealing with the relationship between miRs and pathological factors related to SLE such as genetic background, immune dysregulation and gender-associated differences participating in SLE development. In SLE, distinct miRs are differentially expressed in SLE cells of innate and adaptive immunity. The miR-146a and miR-155 genes, among others, interfere with intracellular signalling pathways downstream of toll-like receptors 7 and 9 (TLR- 7, TLR-9) and influences interferon (IFN)-type I synthesis in plasmacytoid dendritic cells. In T and B cells, miR-126, miR-21, miR-146a, miR-155, miR-1246 and others might influence gene expression by epigenetic modifications, support abnormal cytosine release, differentiation of cell subsets, B cell hyperactivity and autoantibody production. Besides, estrogen might up- and downregulate immunologically active miRs, which are potential mediators of hormonal influences in SLE development. Moreover, SLE genetic basis included some polymorphisms of the miR-146a gene, which varies across populations. CONCLUSION: Distinct miRs are differentially expressed in both SLE mice models and human patients and promote autoimmune features of immune processes. MiRs are important molecules modulating susceptibility to SLE as well as its onset, clinical diversity and progression.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16028824
- 003
- CZ-PrNML
- 005
- 20191126131015.0
- 007
- ta
- 008
- 161005s2016 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2016.004 $2 doi
- 035 __
- $a (PubMed)27003314
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Hušáková, Markéta $u Institute of Rheumatology, Prague, Czech Republic $7 xx0143346
- 245 10
- $a MicroRNAs in the key events of systemic lupus erythematosus pathogenesis / $c M. Husakova
- 520 9_
- $a BACKGROUND: Small non-coding RNA molecules (miRs) are involved in immune cell maturation and function and might influence immunopathological processes of systemic lupus erythematosus (SLE) pathogenesis. METHODS AND RESULTS: This paper presents the results of a literature search for publications dealing with the relationship between miRs and pathological factors related to SLE such as genetic background, immune dysregulation and gender-associated differences participating in SLE development. In SLE, distinct miRs are differentially expressed in SLE cells of innate and adaptive immunity. The miR-146a and miR-155 genes, among others, interfere with intracellular signalling pathways downstream of toll-like receptors 7 and 9 (TLR- 7, TLR-9) and influences interferon (IFN)-type I synthesis in plasmacytoid dendritic cells. In T and B cells, miR-126, miR-21, miR-146a, miR-155, miR-1246 and others might influence gene expression by epigenetic modifications, support abnormal cytosine release, differentiation of cell subsets, B cell hyperactivity and autoantibody production. Besides, estrogen might up- and downregulate immunologically active miRs, which are potential mediators of hormonal influences in SLE development. Moreover, SLE genetic basis included some polymorphisms of the miR-146a gene, which varies across populations. CONCLUSION: Distinct miRs are differentially expressed in both SLE mice models and human patients and promote autoimmune features of immune processes. MiRs are important molecules modulating susceptibility to SLE as well as its onset, clinical diversity and progression.
- 650 _2
- $a adaptivní imunita $x fyziologie $7 D056704
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a B-lymfocyty $x imunologie $7 D001402
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a estrogeny $x fyziologie $7 D004967
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a přirozená imunita $x fyziologie $7 D007113
- 650 _2
- $a systémový lupus erythematodes $x etiologie $x genetika $x imunologie $7 D008180
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a mikro RNA $x genetika $x fyziologie $7 D035683
- 650 _2
- $a jednonukleotidový polymorfismus $x genetika $7 D020641
- 650 _2
- $a T-lymfocyty $x imunologie $7 D013601
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 3 (2016), s. 327-342
- 856 41
- $u http://biomed.papers.upol.cz/ $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20161005 $b ABA008
- 991 __
- $a 20191126131301 $b ABA008
- 999 __
- $a ok $b bmc $g 1169620 $s 953456
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 160 $c 3 $d 327-342 $e 20160321 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- GRA __
- $a NT13707 $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20161005